PDJ
- Product code
- PDJ
- Device name
- Hemoglobin A1c Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1373
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 4
- Summaries archived here
- 4 (direct download)
- 510(k) clearances (all years, FDA)
- 26 (all years; only the last 3 years are listed here)
FDA classification definition
Quantitative determination of Hemoglobin A1c to aid in the diagnosis of diabetes.
510(k) clearances, last 3 years (4)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252749 | 2026-01-06 | Shanghai Medconn Medical Technology Co | Medconn 8K Glycated Hemoglobin Test System | |
| K250073 | 2025-10-03 | Tosoh Bioscience, Inc. | Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01 | |
| K242911 | 2025-06-20 | Shanghai Medconn Medical Technology Co | Medconn Glycated Hemoglobin Test system | |
| K220999 | 2024-09-12 | Shijiazhuang Hipro Biotechnology Co., | Hipro Glycosylated Hemoglobin (HbA1c) Test System |
Official FDA classification page: PDJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).